Atlas Trials

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

RecordFirmDate
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL) (NCT06796998)Izidore Lossos, MD2025-10-13
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. (NCT04223765)UNC Lineberger Comprehensive Cancer Center2020-11-12
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies (NCT03999697)PersonGen BioTherapeutics (Suzhou) Co., Ltd.2018-12-01
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)Mayo Clinic2016-01-19
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection (NCT02109224)National Cancer Institute (NCI)2014-09-01
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709)National Cancer Institute (NCI)2012-04-16
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors (NCT01326702)National Cancer Institute (NCI)2011-07-01
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578)National Cancer Institute (NCI)2010-11-24
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)National Cancer Institute (NCI)2008-10-01
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma (NCT00711828)Mayo Clinic2008-08-01
Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma (NCT00253630)National Cancer Institute (NCI)2005-09-01
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma (NCT00438880)Mayo Clinic2004-10-01
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00082888)National Cancer Institute (NCI)2004-03-24
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms (NCT00082784)National Cancer Institute (NCI)2004-03-01

Track Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue automatically

Every clearance here is in the API, with alerts when new ones post.